Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
about
The use of psychotropic medication during pregnancy: how about the newborn?The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and SwedenSurveillance monitoring for safety of in utero antiretroviral therapy exposures: current strategies and challenges.Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors.Perinatal antidepressant exposure alters cortical network function in rodentsMethodological challenges in using routinely collected health data to investigate long-term effects of medication use during pregnancy.Increased risk of severe congenital heart defects in offspring exposed to selective serotonin-reuptake inhibitors in early pregnancy--an epidemiological study using validated EUROCAT data.Depression during pregnancy: views on antidepressant use and information sources of general practitioners and pharmacists.Maternal use of selective serotonin reuptake inhibitors during pregnancy is associated with Hirschsprung's disease in newborns - a nationwide cohort study.Preschool outcomes following prenatal serotonin reuptake inhibitor exposure: differences in language and behavior, but not cognitive function.In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder.Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy.Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysisNew insights into perinatal depression: pathogenesis and treatment during pregnancy and postpartum.Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.Treatment of nonpsychotic major depression during pregnancy: patient safety and challengesThe Nordic health registers - an important source when evaluating the safety of antidepressants during pregnancy.Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI).Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort studyMood disorders and their pharmacological treatment during pregnancy: is the future child affected?Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis.Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 1: Literature review.Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 2: Testing the hypotheses.Affect Expression and Self-Regulation Capacities of Infants Exposed in utero to Psychotropics.Neonatal SSRI Exposure Programs a Hypermetabolic State in Adult Mice.Stop or go? Preventive cognitive therapy with guided tapering of antidepressants during pregnancy: study protocol of a pragmatic multicentre non-inferiority randomized controlled trial.Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort studyBright light therapy in pregnant women with major depressive disorder: study protocol for a randomized, double-blind, controlled clinical trial.Minimising harm: human variation and adverse drug reactions (ADRs)In utero exposure to antidepressants and the use of drugs for pulmonary diseases in childrenUse of selective serotonin reuptake inhibitors (SSRIs) during pregnancy and disorganized infant-mother attachment.The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.Sertraline exposure leads to small left heart syndrome in adult mice.Psychiatrists' attitudes towards autonomy, best interests and compulsory treatment in anorexia nervosa: a questionnaire survey.Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research.Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.Impact of neonatal sertraline exposure on the post-myocardial infarction outcomes of adult male mice.The effect of regulatory advisories on maternal antidepressant prescribing, 1995-2007: an interrupted time series study of 228,876 pregnancies.Ethics in child and adolescent psychiatric care: An international perspective.
P2860
Q24625025-47CF064B-77A5-4CD3-AE2C-DA7690FB3485Q26741187-8A6358FF-7EBE-4FB2-9D07-C54C1BB23D5CQ28551620-913EEF23-367E-4BDA-ADE4-58A54702A1A0Q30244368-81FE15E0-7D4C-45D3-B30D-C8C1D5353A69Q30395001-A96BA51C-2881-4A14-B6C7-DCEB21B86DA9Q30472853-320CE71D-854E-4D9C-9B1B-E27C1CAC4E49Q30840124-D0C8DDD3-F1DD-41CC-8D4B-271F86539A6AQ30855293-9007FA64-3CE1-409A-9349-6B9FB0DBEED0Q33483653-9FB1BE24-8C43-49A3-A0D3-DC38FAAE4872Q33816388-3892A3D9-DE92-4A6A-844F-A5966B4A5320Q33907544-872620F9-3DA3-4EC8-9FC7-E60432464237Q34040844-5EBB2E5C-02D2-40E9-8A22-904EFE14AAD6Q34073546-B0B39A27-1591-474E-A58C-C78CB6D75BB8Q34144128-F0C1AF5C-C46E-4406-A6C7-74E91D499089Q34177689-6EDFA3BA-EB28-4EC7-8DFA-73B05A046F27Q34178991-C112170D-DF12-47BB-B879-4BB05181F253Q34237681-5D46F3C6-A43F-4078-A735-45CA74ED5AD1Q34240630-1A81E28A-4DD7-4494-B5CC-97A6A50FAA16Q34498504-42A3A0B7-79F4-4C43-860C-509E91FCBCC8Q34702282-70A5F4E0-2B76-4777-ADE7-23C0CD12E723Q34895532-DB5078E9-2B6B-4A09-8D12-408570129C8FQ35132422-AE6BBD83-C4F6-4E9D-B19D-CEE7FB44F0AAQ35640425-FDFC60AD-AD61-44F4-A3E9-63E8D8009558Q35640478-421D911D-0CC5-4DCC-AB13-BBE277D380BFQ35786090-00414F41-A75A-4A9F-81E1-76B78B5E29DEQ35909234-B35F7B8A-4BE1-48BD-9E4F-9D8DF24EB1E5Q35963421-C7173DCF-569F-49E7-A258-A5E4BEF8EB96Q36045075-43F0E129-B3C5-4FF0-9B10-516CA4C9C17AQ36184774-7E593B8D-E0C5-4675-92AD-71D3AA23C22AQ36536395-3607D61B-4FDD-4BFA-9B93-10246D844833Q36609764-0770D112-41DE-40AC-8FD9-B80DFA5A682FQ36687640-F18C4106-2EE8-42F7-A0C5-1A4AA1CBCB6AQ36706789-B0E823BD-46B2-4A0E-A780-5570198B97C0Q36712871-8C0315A5-05F5-40AC-91EB-1B37157604E8Q37040157-CD3CBE97-6AAF-4270-A0C7-BA55DBCD0EBDQ37058701-07F97E48-07A2-42E6-9542-088D216D8729Q37337705-D82A0701-4BBC-4320-88F5-5F4956BDB6CFQ37518414-CBC054B1-D7B8-48BD-934A-8570278A852CQ37606641-B8B06105-1380-4161-9360-723DC3CEBA9AQ37763207-2E3B84E5-AF8B-4EA4-B674-D134B2DA3E58
P2860
Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Increase in use of selective s ...... rt study from the Netherlands.
@ast
Increase in use of selective s ...... rt study from the Netherlands.
@en
type
label
Increase in use of selective s ...... rt study from the Netherlands.
@ast
Increase in use of selective s ...... rt study from the Netherlands.
@en
prefLabel
Increase in use of selective s ...... rt study from the Netherlands.
@ast
Increase in use of selective s ...... rt study from the Netherlands.
@en
P2093
P2860
P1476
Increase in use of selective s ...... ort study from the Netherlands
@en
P2093
Hermien E K de Walle
Lolkje T W de Jong van den Berg
Paul B van den Berg
Pieternel Kölling
P2860
P304
P356
10.1111/J.1365-2125.2007.03048.X
P407
P577
2007-10-22T00:00:00Z